CEFTRAX TZ 1.125

About CEFTRAX TZ 1.125

Brand Name: CEFTRAX 1.125 TZ
Generic Name / Content: Ceftriaxone + Tazobactam Injection I.P. 1.125 g
Company: Aurobindo Pharma Ltd

CEFTRAX 1.125 TZ Injection is a combination antibiotic containing Ceftriaxone (a third-generation cephalosporin) and Tazobactam (a beta-lactamase inhibitor). This dual-action formulation provides broad-spectrum antibacterial activity, including efficacy against beta-lactamaseproducing bacteria.

Ceftriaxone inhibits bacterial cell wall synthesis, while Tazobactam prevents enzymatic degradation of the antibiotic, enhancing overall effectiveness. This sterile injectable formulation is suitable for intravenous (IV) or intramuscular (IM) administration in hospitals and clinical settings.

Indications

         Severe respiratory tract infections (pneumonia, bronchitis, sinusitis)

         Urinary tract infections (UTIs)

         Skin and soft tissue infections

         Bone and joint infections

         Intra-abdominal infections

         Septicemia and bacteremia

         Gynecological infections

         Surgical prophylaxis

Key Features

         Third-generation cephalosporin combined with a beta-lactamase inhibitor

         Broad-spectrum antibacterial coverage

         Effective against resistant bacterial strains

         Sterile injectable formulation for IV or IM use

         Manufactured by Aurobindo Pharma Ltd

Dosage Form & Category

         Dosage Form: Injection (Vial)

         Category: Injectable / Parenteral Antibiotic

         Strength: 1.125 g per vial

         Content: Ceftriaxone + Tazobactam

Packaging & Storage

         Supplied in sterile vial packaging

         Store in a cool, dry place below 25C

         Protect from light

         Use under qualified medical supervision